Immune response to tetravalent meningococcal vaccine: opsonic and bactericidal functions of normal and properdin deficient sera
- PMID: 2496990
- DOI: 10.1007/BF01965264
Immune response to tetravalent meningococcal vaccine: opsonic and bactericidal functions of normal and properdin deficient sera
Abstract
Neisseria meningitidis serogroup W-135 appears to be a fairly common cause of infection associated with properdin deficiency or dysfunction, and anticapsular antibodies might be protective in these patients. For this reason, bactericidal and opsonophagocytic activities for serogroup W-135 were investigated before and four weeks after vaccination of two properdin-deficient adults with tetravalent meningococcal vaccine. In addition, the response of IgM, IgG and IgA class antibodies to the serogroups A, C, Y and W-135 was determined by ELISA. There was no evidence of poor antibody responses in the properdin-deficient persons. Vaccination promoted classical pathway-mediated killing in serum and opsonization of serogroup W-135 to the same extent as that seen in vaccinated controls. The increase of alternative pathway-mediated killing in the properdin-deficient sera was moderate, but vaccination clearly enhanced alternative pathway-mediated opsonophagocytosis in the sera. It was also shown that vaccination markedly reduced the requirement for properdin in alternative pathway-mediated killing of the meningococci.
Similar articles
-
Complement deficiency states and meningococcal disease.Immunol Res. 1993;12(3):295-311. doi: 10.1007/BF02918259. Immunol Res. 1993. PMID: 8288947 Review.
-
Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG.J Clin Immunol. 2000 Mar;20(2):138-49. doi: 10.1023/a:1006638631581. J Clin Immunol. 2000. PMID: 10821465
-
Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine.Clin Exp Immunol. 1998 Dec;114(3):362-9. doi: 10.1046/j.1365-2249.1998.00738.x. Clin Exp Immunol. 1998. PMID: 9844044 Free PMC article. Clinical Trial.
-
Bactericidal activity for Neisseria meningitidis in properdin-deficient sera.J Infect Dis. 1987 Jul;156(1):107-12. doi: 10.1093/infdis/156.1.107. J Infect Dis. 1987. PMID: 3110302
-
Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease.Vaccine. 2009 Jun 24;27 Suppl 2(Suppl 2):B117-25. doi: 10.1016/j.vaccine.2009.04.066. Epub 2009 May 23. Vaccine. 2009. PMID: 19477054 Free PMC article. Review.
Cited by
-
Complement deficiency states and meningococcal disease.Immunol Res. 1993;12(3):295-311. doi: 10.1007/BF02918259. Immunol Res. 1993. PMID: 8288947 Review.
-
Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG.J Clin Immunol. 2000 Mar;20(2):138-49. doi: 10.1023/a:1006638631581. J Clin Immunol. 2000. PMID: 10821465
-
Infectious diseases associated with complement deficiencies.Clin Microbiol Rev. 1991 Jul;4(3):359-95. doi: 10.1128/CMR.4.3.359. Clin Microbiol Rev. 1991. PMID: 1889047 Free PMC article. Review.
-
Infections of people with complement deficiencies and patients who have undergone splenectomy.Clin Microbiol Rev. 2010 Oct;23(4):740-80. doi: 10.1128/CMR.00048-09. Clin Microbiol Rev. 2010. PMID: 20930072 Free PMC article. Review.
-
Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine.Clin Exp Immunol. 1998 Dec;114(3):362-9. doi: 10.1046/j.1365-2249.1998.00738.x. Clin Exp Immunol. 1998. PMID: 9844044 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous